Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07400718 · ClinicalTrials.gov registry record · NA
Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators
A NA study, sponsored by QHSLab.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07400718: Completed NA study, sponsored by QHSLab.
NCT07400718 is a NA study that has completed, run by QHSLab. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07400718, a NA study, has completed, sponsored by QHSLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This clinical study, titled "Head-to-Head Comparison Study between Different FDA Registered Allergy Skin Test Applicators," aims to compare the reliability and clinical performance of three skin prick test (SPT) devices: Allertest™ Multiple Skin Test Applicator, Lincoln Multi-Test II, and Greer Skintestor OMNI Applicator. The primary objective is to evaluate the consistency and accuracy of these devices in allergy testing.
Primary Outcome
Procedural pain assessed immediately after device application using a 0-10 Visual Analog Scale (VAS), where 0 represents no pain and 10 represents unspeakable pain. Lower scores indicate less pain and better tolerability.
Interventions
- DEVICE AllerTest-10 Multi-Head Skin Test Device
- DEVICE Skintestor OMNI Multi-Head Skin Test Device
- DEVICE Multi-Test II Multi-Head Skin Test Device
- DEVICE AllerTest-8 Multi-Head Skin Test Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-11-12 |
| Est. Completion | 2026-01-30 |
| Phase | NA |
What the finished NCT07400718 record still lists
NCT07400718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which AllerTest-10 Multi-Head Skin Test Device is the first listed.
NCT07400718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07400718 about?
NCT07400718 is a clinical study titled "Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators". This clinical study, titled "Head-to-Head Comparison Study between Different FDA Registered Allergy Skin Test Applicators," aims to compare the reliability and clinical performance of three skin prick test (SPT) devices: Allertest™ Multiple Skin Test Applicator, Lincoln Multi-Test II, and Greer Skin...
What is the current status of trial NCT07400718?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2025-11-12. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT07400718?
The interventions under investigation include: AllerTest-10 Multi-Head Skin Test Device (DEVICE), Skintestor OMNI Multi-Head Skin Test Device (DEVICE), Multi-Test II Multi-Head Skin Test Device (DEVICE), AllerTest-8 Multi-Head Skin Test Device (DEVICE).
Who is sponsoring clinical trial NCT07400718?
This trial is sponsored by QHSLab, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07400718's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI